
HIV Vaccine Research Stalls as U.S. Funding Cuts Halt Critical Trials
Years of Work Toward a Vaccine Abruptly Cut Off After nearly 15 years of focused research, immunologist Dennis Burton was preparing to begin trials on a promising HIV vaccine candidate. His team’s efforts, backed by a $258 million government grant, were part of one of the most advanced programs in